YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Beyond Air™ GARDEN CITY, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' li…
Beyond Air, Inc. Q1 2027 Earnings Call Summary - Moby Strategic Execution and Commercial Foundation Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pi…
(RTTNews) - Today's top biotech gainers include Universe Pharmaceuticals, which recently filed its SEC report for the six months ended March 31, 2026; Cumberland Pharma, ahead of its second-quarter 2026 financial results due Tuesday; and A…
Image source: The Motley Fool. DATE Friday, June 26, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Robert GoodmanChief Financial Officer - Dan Moorhead Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAWAYS…
Major earnings expected before the bell on Friday include: * Apogee Enterprises (APOG [https://seekingalpha.com/symbol/APOG]) * Cineverse Corp. (CNVS [https://seekingalpha.com/symbol/CNVS]) * Beyond Ai (XAIR [https://seekingalpha.com/symbo…
GARDEN CITY, N.Y., June 22, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to i…
Beyond Air™ GARDEN CITY, N.Y., June 01, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients’ liv…
Beyond Air™ GARDEN CITY, N.Y., April 01, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients’ li…
* Beyond Air (XAIR [https://seekingalpha.com/symbol/XAIR]) on Thursday said that Chief Executive Officer Steve Lisi has resigned and stepped down from the board, effective March 27, to pursue other opportunities. * The company appointed Ch…
GARDEN CITY, N.Y., March 17, 2026 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an investigational immunotherapeutic for solid tumors and subsidiar…
Virtual Investor Conferences NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, h…
NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are no…
Virtual Investor Conferences Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary inve…
GARDEN CITY, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to…
Beyond Air Inc (NASDAQ:XAIR) is among the best NASDAQ penny stocks to buy according to analysts. On February 20, Beyond Air Inc (NASDAQ:XAIR) commented that it was pleased with a review article that recognized the potential of high-dose ni…
Beyond Air, Inc. Q3 2026 Earnings Call Summary - Moby Strategic Execution and Operational Scaling Revenue grew 105% year-over-year to $2.2 million, driven by expanded adoption of the first-generation LungFit PH system across more than 45 h…
* Beyond Air press release [https://seekingalpha.com/pr/20399074-beyond-air-reports-fiscal-third-quarter-2026-financial-results-and-provides-corporate-update] (XAIR [https://seekingalpha.com/symbol/XAIR]): Q3 GAAP EPS of -$0.85 misses by $…
GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to i…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Beyond Air Inc. 191,204,757 2.43 1.37 2.0881 +1.2121 CCSC TECHNOLOGY INTL.…
Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA Orphan D…
(RTTNews) - Beyond Air, Inc. (XAIR), a commercial-stage medical device and biopharmaceutical company, on Tuesday announced that it has appointed Dan Moorhead as Chief Financial Officer, effective January 5, 2026. Duke Dewrell, the Company'…
* Beyond Air (XAIR [https://seekingalpha.com/symbol/XAIR]) announced on Tuesday the appointment of Dan Moorhead as chief financial officer (CFO), effective January 5, 2026. * From June 2017 to August 2025, Moorhead served as chief financia…
GARDEN CITY, N.Y., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to i…
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to announce it will host the 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025, at the Metropolitan C…
* Beyond Air, Inc. (NASDAQ: XAIR [https://seekingalpha.com/symbol/XAIR]) has filed a prospectus to allow for the resale of 719,561 shares of common stock by existing warrant holders. * The shares are issuable upon exercise of outstanding w…
GARDEN CITY, N.Y., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to…
GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to…
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT RAPP [https://www.char…
Curious about the most active stocks on Monday? Find out which stocks are dominating the market action! [mostactive] TOP MOST ACTIVE STOCKS TICKER CHANGE COMMENT OPEN [https://www.chartmill.com/stock/quote/OPEN/profile] 1.92% Today, the ma…
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. [topmovers] TOP GAINERS TICKER CHANGE COMMENT RAPP [https://www.chartmill.com/stock/quote/RAPP/profile] 111.0% RAPPORT THERAPE…
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. [gap] GAP UP STOCKS TICKER CHANGE COMMENT XAIR [https://www.chartmill.com/stock/quote/XAIR/profile] 88.24% BEYOND AIR INC'…
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMMENT HOUR [https://www.chartmill.com/st…
GARDEN CITY, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to…
As the U.S. stock market continues to navigate a landscape of political maneuvers and economic indicators, with major indices closing higher despite recent concerns, investors remain focused on strategic opportunities within growth sectors…
GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to i…
Key Points Revenue climbed 157% year over year to $1.8 million (GAAP), but missed analyst estimates by 27.5% (GAAP). Earnings per share (GAAP) improved to $(1.53), beating the prior-year quarter but falling short of the consensus estimate…